Related Experiment Video

Updated: May 1, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

5.7K

Disruption of mutated BRAF signaling modulates thyroid cancer phenotype

Elyse K Hanly, Shilpi Rajoria, Zbigniew Darzynkiewicz

  • 1Department of Microbiology and Immunology, New York Medical College, Valhalla, New York 10595, USA. Raj_Tiwari@nymc.edu.

BMC Research Notes
|March 29, 2014
PubMed
Abstract

Insights

The BRAFV600E mutation drives thyroid cancer. PLX4032, a BRAFV600E inhibitor, effectively reduces proliferation in mutated thyroid cancer cells by targeting the MAPK pathway.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Thyroid cancer is the most common endocrine cancer in the US, with rising incidence.
  • The BRAFV600E mutation is prevalent in papillary (50%) and anaplastic (25%) thyroid cancers.
  • This mutation presents a target for specialized drug therapies.

Purpose of the Study:

  • To investigate the effects of PLX4032, a BRAFV600E inhibitor, on normal thyroid cells and BRAFV600E-positive thyroid cancer cells.
  • To evaluate the drug's impact on cell proliferation, death, cell cycle, and MAPK pathway signaling.

Main Methods:

  • Proliferation assays and immunofluorescence for cell death analysis.
  • EdU uptake assay and laser scanning cytometry for cell cycle determination.
  • Western blot analysis of MAPK pathway protein expression.

Main Results:

  • PLX4032 demonstrated significant anti-proliferative effects exclusively in BRAFV600E-mutated thyroid cancer cells.
  • Inhibition of downstream MAPK signaling molecules by PLX4032 underlies these anti-proliferative effects.
  • Conversely, PLX4032 enhanced phosphorylation of MAPK pathway molecules in BRAF-wild-type cells.

Conclusions:

  • PLX4032 shows selective efficacy against BRAFV600E-mutated thyroid cancer.
  • Further research into combination therapies involving BRAFV600E inhibitors is warranted for patients with this mutation.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K
Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K